Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Lower Respiratory Tract Infection
100%
Namibia
100%
Antibiotic Susceptibility Pattern
100%
Bacterial Isolates
100%
Referral Hospital
100%
Intensive Care Unit Patients
100%
Intensive Care Unit
83%
Klebsiella Pneumoniae (K. pneumoniae)
50%
Carbapenem
50%
Antibiotics
33%
Colistin
33%
Windhoek
33%
Amikacin
33%
Central Hospitals
33%
Susceptibility Pattern
33%
Tigecycline
33%
Cumulative Antibiogram
33%
Antibiotic Use
16%
Public Health Risk
16%
Patient Management
16%
Health Systems
16%
Cause of Death
16%
Rifampicin
16%
Gentamicin
16%
Sub-Saharan African Countries
16%
Meropenem
16%
Vancomycin
16%
Linezolid
16%
Current Guidelines
16%
Pseudomonas Aeruginosa (P. aeruginosa)
16%
Common Pathogens
16%
Baumannii
16%
Enterobacter
16%
Empirical Therapy
16%
Antibiotic Combination
16%
Cross-sectional Analytical Study
16%
Gram-negative Pathogens
16%
Local Setting
16%
Teicoplanin
16%
S. Maltophilia
16%
Medicine and Dentistry
Antibiogram
100%
Lower Respiratory Tract Infection
100%
Intensive Care Unit
100%
Patient Referral
100%
Pathogen
66%
Carbapenem Derivative
50%
Pneumonia
50%
Colistimethate
33%
Amikacin
33%
Tigecycline
33%
Antimicrobial Agent
33%
Antibiotics
33%
Patient Care
16%
Cross Sectional Study
16%
Public Health
16%
Health System
16%
Gentamicin
16%
Meropenem
16%
Pseudomonas aeruginosa
16%
Staphylococcus Aureus
16%
Vancomycin
16%
Enterobacter
16%
Rifampicin
16%
Teicoplanin
16%
Linezolid
16%
Empirical evidence
16%
Nursing and Health Professions
Patient Referral
100%
Lower Respiratory Tract Infection
100%
Intensive Care Unit
100%
Pneumonia
50%
Carbapenem Derivative
50%
Amikacin
33%
Colistimethate
33%
Antimicrobial Agent
33%
Tigecycline
33%
Practice Guideline
16%
Patient Care
16%
Antibiotic Agent
16%
Vancomycin
16%
Meropenem
16%
Gentamicin
16%
Cross-Sectional Study
16%
Public Health
16%
Rifampicin
16%
Teicoplanin
16%
Linezolid
16%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotics
100%
Lower Respiratory Tract Infection
100%
Infectious Agent
66%
Carbapenem Derivative
50%
Pneumonia
50%
Amikacin
33%
Colistimethate
33%
Tigecycline
33%
Antimicrobial Agent
33%
Antibiotic Agent
16%
Gentamicin
16%
Rifampicin
16%
Linezolid
16%
Vancomycin
16%
Meropenem
16%
Staphylococcus Aureus
16%
Pseudomonas aeruginosa
16%
Enterobacter
16%
Teicoplanin
16%
Cross-Sectional Study
16%